Last updated on March 2018

A clinical trial seeking patients for a research study of Alcaftadine Ophthalmic Solution 0.25%

Brief description of study

This post-marketing surveillance study will assess the safety and efficacy of Lastacaft Opthalmic Solution 0.25% (Alcaftadine) for the prevention of itching associated with Allergic Conjunctivitis as prescribed as standard of care in clinical practice in Korea.

Clinical Study Identifier: NCT02555761

Contact Investigators or Research Sites near you

Start Over

Clinical Trials Registry Team

Onuri Eye Hospital
Jeollabuk-do, Korea, Republic of
  Connect »